Viewing Study NCT01013961


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-02-22 @ 2:44 PM
Study NCT ID: NCT01013961
Status: TERMINATED
Last Update Posted: 2023-06-28
First Post: 2009-11-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Sponsor: ECOG-ACRIN Cancer Research Group
Organization: